Hero image

About our company

We invent for a more hopeful future.

We aspire to be the premier research-intensive biopharmaceutical company in the world

For more than 125 years, MSD has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of our mission to save and improve lives.

We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships.

Today, we continue to be at the forefront of research to prevent and treat diseases that threaten people and animals – including cancer, infectious diseases, such as HIV and Ebola, and emerging animal diseases.

 

Watch highlights of our discoveries and commitments from the start of our company to today.

primary article image
Responsibility

The heart of our mission

We believe corporate responsibility is about our health, social, environmental and economic impact on people and communities around the world.

Leadership

The team that guides our work

Our leaders focus on our mission to save and improve lives around the world. This is the foundation of everything we do.

Our company by the numbers

145

employees

Our culture
$9.9B

research and development investment in 2019

Our research
$2.8B

total philanthropy in 2018

Our giving

MSD in Belgium

MSD has 2 sites in Belgium: 2 are located in Brussels - Woluwe & Schuman. The MSD site in Grand Duchy of Luxembourg is located in Windhof.

Brussels, Woluwe
Brussels, Schuman
Luxembourg, Windhof

Anchored in Belgium & Luxembourg

At MSD Belgium & Luxembourg, more than 370 people work in national and international positions in various areas (as of 01/19). Belgium is one of more than 50 countries in which MSD conducts clinical research.

Research and Development

Manufacturing, Production and Quality Assurance

Marketing and Distribution

Human Resources, Supply Chain Management, Finance, IT

Serve patients in more than 140 countries

MSD

Our company has been active in Belgium since 1965 and is committed to strengthen health literacy and health economics, among other things. In 2018, MSD Belgium received the “Top Employer” and “Top Employer Europe” certifications for the third time in a row.

Culture & values

Our values are driven by a desire to improve life

We’ve built a culture that embraces scientific excellence, operates with the highest standards of integrity, expands access to our products and employs a diverse workforce that values collaboration.

History

Our past and our future

For more than 125 years, we’ve focused on not just the next quarter, but the next quarter century.

Get to know us through our stories

Learn about the heartbeat of our company.

View our stories

Cliniclowns bring resilience and lightness for children in need

“Cliniclowns” visit sick or disabled children in hospitals and offer them a moment of joy. Cliniclowns put these children into the center of everything they do. Therefore, they deserve MSD Belux’s attention and support. Cliniclowns Belgium has been sending professional clowns to sick and/or disabled children for over twenty years to give them comfort and […]

Read more

Next: Cliniclowns bring resilience and lightness for children in need

Launch of Coalition Next in Belgium

Coalition Next was first founded in 2020 in France by Digital Pharma Lab in the context of the Corona pandemic. It is a coalition of pharmaceutical industries, patient organizations, and healthcare organizations, that launches once or twice a year, a call for projects for start-ups in digital health and medical devices to meet the pre-identified […]

Read more

Next: Launch of Coalition Next in Belgium

MSD invests in health literacy with klarekijkopkanker.be

Health literacy, or a better understanding of their illness, is invaluable to the quality of life of cancer patients. Freya Rowaert knows this all very well too. She is 44 and has been living with cancer for 20 years. And she has been working for MSD for just as long. We are proud that, together […]

Read more

Next: MSD invests in health literacy with klarekijkopkanker.be

Results from the MSD’s #CancerScreening Barometer 2021

The MSD #CancerScreening Barometer is a survey that reflects the knowledge and attitude of the Belgian population towards cancer screening. Cancer screening is an important factor that positively impacts disease outcome, unfortunately, the survey shows that 6 out of 10 Belgians have the feeling they lack information on screening. Belgium is at the European top regarding breast cancer screening But 78% of surveyed […]

Read more

Next: Results from the MSD’s #CancerScreening Barometer 2021

Finding yourself after surviving head and neck cancer

Head and neck cancer will impact not only someone’s health, but also someone’s sense of self. Paolo Berti survived head and neck cancer caused by the papillomavirus. In two years time, three tumors had to be removed. For the first tumor they used chemoradiotherapy, for the second a lymph node dissection and for the third […]

Read more

Next: Finding yourself after surviving head and neck cancer

Cliniclowns bring resilience and lightness for children in need

“Cliniclowns” visit sick or disabled children in hospitals and offer them a moment of joy. Cliniclowns put these children into the center of everything they do. Therefore, they deserve MSD Belux’s attention and support. Cliniclowns Belgium has been sending professional clowns to sick and/or disabled children for over twenty years to give them comfort and […]

Read more

Next: Cliniclowns bring resilience and lightness for children in need

Launch of Coalition Next in Belgium

Coalition Next was first founded in 2020 in France by Digital Pharma Lab in the context of the Corona pandemic. It is a coalition of pharmaceutical industries, patient organizations, and healthcare organizations, that launches once or twice a year, a call for projects for start-ups in digital health and medical devices to meet the pre-identified […]

Read more

Next: Launch of Coalition Next in Belgium

MSD invests in health literacy with klarekijkopkanker.be

Health literacy, or a better understanding of their illness, is invaluable to the quality of life of cancer patients. Freya Rowaert knows this all very well too. She is 44 and has been living with cancer for 20 years. And she has been working for MSD for just as long. We are proud that, together […]

Read more

Next: MSD invests in health literacy with klarekijkopkanker.be

Results from the MSD’s #CancerScreening Barometer 2021

The MSD #CancerScreening Barometer is a survey that reflects the knowledge and attitude of the Belgian population towards cancer screening. Cancer screening is an important factor that positively impacts disease outcome, unfortunately, the survey shows that 6 out of 10 Belgians have the feeling they lack information on screening. Belgium is at the European top regarding breast cancer screening But 78% of surveyed […]

Read more

Next: Results from the MSD’s #CancerScreening Barometer 2021

Finding yourself after surviving head and neck cancer

Head and neck cancer will impact not only someone’s health, but also someone’s sense of self. Paolo Berti survived head and neck cancer caused by the papillomavirus. In two years time, three tumors had to be removed. For the first tumor they used chemoradiotherapy, for the second a lymph node dissection and for the third […]

Read more

Next: Finding yourself after surviving head and neck cancer

Previous
Next

Our areas of focus

Through innovation and scientific excellence, we deliver vaccines and medicines that may help millions of people around the world.

Oncology

Our mission is to deliver innovations that extend and improve the lives of people with cancer.

Learn about oncology

Vaccines

Vaccines are one of the greatest public health success stories – and we’ve been discovering, developing and delivering vaccines to help prevent disease for over 100 years.

Learn about vaccines

Infectious diseases

We play an important role in discovering and developing innovative medicines and vaccines to treat and prevent infectious diseases, including HIV and Ebola.

Learn about infectious diseases

COVID-19

As a company dedicated to saving and improving lives, we have a special responsibility to help in the fight against COVID-19. We’ve been fully committed to developing an effective response to the COVID-19 pandemic since it was first recognized.

Learn more about our response to COVID-19

Discovery & Development

We are pushing the boundaries in research where we can make the greatest difference, now and in the future.

Learn about our work